Trial Details

COMPLETED
Basic Information
Clinical ID c1190
Identifier NCT00064454
Trial Title FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions DRUG: OPC-6535 Tablets (drug)
Participant Information
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
City Phoenix
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2025-05-03
Primary Completion Date 2025-07-06
Completion Date 2025-07-06